COVID-19 Vaccine Update:US,Russia,China Claim Mojor Breakthrough,India Starts Trials

     

Amidst the urgency to develop the coronavirus vaccine at the earliest, various countries are now claiming to be in different stages of trials of the vaccine. Here are selected for you the updates on the development of the vaccine around the world.

Vaccine in India:

         

COVAXIN has entered the human trials phase.It is jointly developed by Bharat Biotech, Indian Council of Medical Research (ICMR), and National Institute of Virology, Pune.
The clinical trial has started at the All India Institutes of Medical Sciences (AIIMS), Patna. Another potential candidate Zydus Cadila is still at Phase I.
AIIMS-Patna has commenced testing the candidate vaccine on 10 volunteers picked by the hospital authority for the trial, reported AIR.

According to the report, the first dose of the vaccine has been administered to the study participants, who will be given the second dose at an interval of 14 days.

Vaccine in USA:

      

Biotech firm Moderna Inc's experimental vaccine for COVID-19 showed it was safe and provoked immune responses in all 45 healthy volunteers in an ongoing early-stage study, U.S. researchers revealed on Tuesday
Volunteers who got two doses of the vaccine had high levels of virus-killing antibodies that exceeded the average levels seen in people who had recovered from COVID-19, the team disclosed in the New England Journal of Medicine.
The US will deliver a Coronavirus COVID19 vaccine in the “record-breaking time”, stated American President Donald Trump.
The US President has declared that America will deliver a COVID19 vaccine in record-breaking time through “Operation Warp Speed”.

Vaccine in Russia:

   
   
Russian scientists said they are aiming to launch the vaccine by mid-August, says a report.
According to Director of the Gamaleya Scientific Research Institute, Alexander Gintsburg, there are expectstions that "a small amount" of the vaccine would be available to people in the middle of August, and private companies could start producing vaccines in the beginning or the middle of September, as reported by Sputnik News.
The head of the research institute added that the vaccine may not be available in pharmacies in the near future.

Vaccine in China:

      

CanSino Biologics looks to be one of the front runners in the race to develop a vaccine for the novel coronavirus.
The vaccine candidate of the Chinese drugmaker has been approved for limited usage for the military in China for a period of one year.
Its vaccine candidate Ad5-nCoV is developed with the use of the drugmaker's adenovirus-based viral vector vaccine technology platform.

Coronavirus vaccine UK, Oxford, AstraZeneca

      

In the UK, two potential Coronavirus vaccine candidates have raised hope. One is developed by the University of Oxford and AstraZeneca is at Phase III. Another is being developed by Imperial College London and its has entered the Phase II stage.

Comments

Popular posts from this blog

No Time Frame Yet For Schools Reopening ,Says FGN

Want To Enjoy A Fantastic Heallth?5 Simple Rules To Obey

COVID-19:Now mobile apps and dashboards available for update. How can this help you?

Ogun State To Reopen Schools Sept 21,To Adopt Staggered Timetables

COVID-19:Lagos State House Visits Schools For Safety Protocols Assessment

Incredible Story Of The Fattest Kid In The World Who Lost 105 kg

Want To be Productive And Full Of Energy? 12 Best Food To Eat In The Morning

Would you like to keep your kidneys from being continuously damaged?You must stop these bad habits

Schools Reopening:Lagos State Approves 20/21 Academic Calendar

Schools Reopening:Ogun State Grants Automatic Promotion To All Students